Sequoia Financial Advisors LLC Has $2.29 Million Holdings in Humana Inc. $HUM

Sequoia Financial Advisors LLC raised its position in shares of Humana Inc. (NYSE:HUM) by 55.6% in the second quarter, Holdings Channel.com reports. The institutional investor owned 5,753 shares of the insurance provider’s stock after buying an additional 2,055 shares during the period. Sequoia Financial Advisors LLC’s holdings in Humana were worth $2,285,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Manning & Napier Advisors LLC acquired a new stake in Humana during the 2nd quarter valued at $1,412,000. Sustainable Insight Capital Management LLC grew its holdings in shares of Humana by 23.7% during the fourth quarter. Sustainable Insight Capital Management LLC now owns 24,757 shares of the insurance provider’s stock valued at $6,341,000 after buying an additional 4,740 shares in the last quarter. Pzena Investment Management LLC acquired a new position in Humana during the second quarter valued at $1,749,014,000. North Dakota State Investment Board acquired a new position in Humana during the fourth quarter valued at $1,517,000. Finally, California State Teachers Retirement System lifted its stake in Humana by 39,982.9% in the 2nd quarter. California State Teachers Retirement System now owns 68,644,780 shares of the insurance provider’s stock worth $27,267,080,000 after acquiring an additional 68,473,523 shares in the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Humana Trading Down 0.2%

NYSE:HUM opened at $408.79 on Monday. Humana Inc. has a 12 month low of $163.11 and a 12 month high of $428.88. The firm has a market cap of $49.09 billion, a price-to-earnings ratio of 38.67, a P/E/G ratio of 2.53 and a beta of 0.74. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.62. The company’s 50 day moving average is $388.94 and its 200-day moving average is $304.40.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share for the quarter, topping the consensus estimate of $7.27 by $0.34. The business had revenue of $40.89 billion during the quarter, compared to analysts’ expectations of $40.58 billion. Humana had a return on equity of 11.20% and a net margin of 0.88%.The firm’s revenue was up 26.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $6.27 EPS. Equities analysts anticipate that Humana Inc. will post 9 EPS for the current year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, November 27th. Shareholders of record on Friday, October 30th will be given a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 0.9%. The ex-dividend date is Friday, October 30th. Humana’s dividend payout ratio (DPR) is currently 33.49%.

Analyst Ratings Changes

A number of equities research analysts have commented on the company. Morgan Stanley upgraded Humana from an “underweight” rating to an “equal weight” rating and raised their price objective for the stock from $249.00 to $370.00 in a research report on Tuesday, August 4th. Sanford C. Bernstein restated an “outperform” rating and set a $425.00 price target on shares of Humana in a report on Wednesday, June 3rd. Bank of America raised shares of Humana from a “neutral” rating to a “buy” rating and set a $500.00 price objective on the stock in a research report on Wednesday, July 29th. Wells Fargo & Company upgraded shares of Humana from an “equal weight” rating to an “overweight” rating and increased their target price for the stock from $227.00 to $502.00 in a research report on Monday, July 13th. Finally, Robert W. Baird set a $390.00 price target on shares of Humana in a report on Thursday, July 30th. Fourteen analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $403.91.

Humana Company Profile

Humana Inc (NYSE:HUM) is a U.S.-based health insurance and health care services company focused primarily on government-sponsored programs. Its offerings include Medicare Advantage plans, Medicare prescription drug plans, Medicaid coverage and specialty insurance products, serving individuals, employers and government organizations.

Through its CenterWell business, Humana also provides senior-focused primary care, pharmacy services and home health care. These operations are designed to support coordinated care for older adults and other members with ongoing health care needs.

Humana was founded in 1961 as a nursing-home company and later expanded into hospital ownership before shifting its focus toward health insurance.